Lowell Blake & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Lowell Blake & Associates's EW Position: Q3 2023 in Review
Lowell Blake & Associates increased its Edwards Lifesciences (EW) stake by 10% in Q3 2023, buying an estimated $1.05M and bringing the position to 143,242 shares worth $9.92M. The position accounts for 2.8% of the portfolio, ranked #14.
Lowell Blake & Associates first reported a position in EW in Q4 2019 and has held it in 16 quarters since. The position peaked at $12.3M in Q2 2023. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.
- Lowell Blake & Associates held 143,242 shares of Edwards Lifesciences worth $9.92M as of Q3 2023.
- Lowell Blake & Associates bought 13,121 Edwards Lifesciences shares in Q3 2023, an estimated $1.05M.
- Edwards Lifesciences made up 2.8% of Lowell Blake & Associates's portfolio in Q3 2023, its #14 holding.
- Lowell Blake & Associates first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 16 quarters since.
- Lowell Blake & Associates's Edwards Lifesciences position peaked at $12.3M in Q2 2023.
- 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.
Based on Lowell Blake & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.